IntroductionCell and Gene Therapy (CGT) is transforming the treatment landscape for difficult-to-treat diseases, particularly cancers and rare disorders. However, the path from lab to market remains s...
As Cell and Gene Therapy (CGT) products transition from the laboratory to the clinic, the design of the clinical trial protocol is not only the starting point for scientific exploration but also the c...
When an innovative therapy aiming for a "one-time cure" is still evaluated by traditional standards that measure "months of survival," its failure may have been predetermined. In 2...
